The American Cleaning Institute (ACI, formerly known as the Soap and Detergent Association) asserts that the Environmental Protection Agency (EPA) should summarily reject a petition by activist groups to ban an important antibacterial chemical, as the petition is deficient, lacks merit and uniformly fails to provide relevant evidence.
In formal comments to the EPA, ACI noted that triclosan is a germ-killing ingredient in personal care and hand hygiene products, which are regulated by the Food and Drug Administration, not the EPA.
"These products play a beneficial role in the daily hygiene routines of millions of people throughout the U.S. and worldwide," wrote Richard Sedlak, ACI's senior vice president of technical and international affairs. "They have been and are used safely and effectively in homes, hospitals, and workplaces every single day. Furthermore, triclosan and products containing it are regulated by a number of governmental bodies around the world and have a long track record of human and environmental safety which is supported by a multitude of scientifically based transparent risk analyses."
ACI says it took exception to the activist groups request for EPA to ban triclosan, stating that the EPA completed a very thorough review of the ingredient in a 2008 regulatory decision that formally re-registered triclosan for its use in EPA-regulated products. The petitioners attacks on triclosans safety and effectiveness rely on scientific bias, fail to present new relevant research that could impact EPAs findings, and appear to rely on an uninformed view of the established EPA re-registration process, according to ACI.
The ACI's comments summarize science-based research and data that show triclosan is safe for use in regulated hygiene products, does not cause significant risks or harm to human health and the environment, and does not contribute to bacterial resistance.
"In real-world situations such as the home, food manufacturing, and industrial environments, there is no evidence that antimicrobials can select for antibiotic resistant bacteria," wrote Sedlak.
ACI reiterated that triclosan-containing antibacterial handwash products provide a benefit compared to non-antibacterial hand wash products. "Antibacterial handwashes provide a public health benefit by reducing or eliminating pathogenic bacteria on the skin to a significantly greater degree than plain soap and water. The bacterial reduction from handwashing is linked to reduced infection from pathogenic bacteria."
Tackling Health Care-Associated Infections: SHEA’s Bold 10-Year Research Plan to Save Lives
December 12th 2024Discover SHEA's visionary 10-year plan to reduce HAIs by advancing infection prevention strategies, understanding transmission, and improving diagnostic practices for better patient outcomes.
Point-of-Care Engagement in Long-Term Care Decreasing Infections
November 26th 2024Get Well’s digital patient engagement platform decreases hospital-acquired infection rates by 31%, improves patient education, and fosters involvement in personalized care plans through real-time interaction tools.
The Leapfrog Group and the Positive Effect on Hospital Hand Hygiene
November 21st 2024The Leapfrog Group enhances hospital safety by publicizing hand hygiene performance, improving patient safety outcomes, and significantly reducing health care-associated infections through transparent standards and monitoring initiatives.
The Importance of Hand Hygiene in Clostridioides difficile Reduction
November 18th 2024Clostridioides difficile infections burden US healthcare. Electronic Hand Hygiene Monitoring (EHHMS) systems remind for soap and water. This study evaluates EHHMS effectiveness by comparing C difficile cases in 10 hospitals with CMS data, linking EHHMS use to reduced cases.